Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethacridine lactate versus povidone-iodine for wound care after circumcision
ChiCTR2600131923Phase 4Not yet recruiting
- Sponsor
- Guangyuan First People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ethacridine and povidone-iodine in phimosis and Redundant prepuce (2 arms), sponsored by Guangyuan First People's Hospital. Primary endpoint: Healing time of wound edges after circumcision. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ethacridinepovidone-iodine
03
Conditions
phimosisRedundant prepuce
Beyond the preview
Go deeper on ChiCTR2600131923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600131923.